MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,326K
EPS
-$0.21
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
-
-
85*
-
General and administrative
1,555
1,936
1,754*
1,577
Total costs and expenses
1,555
1,936
1,839
1,577
Loss from operations
-1,555
-1,936
-1,839*
-1,577
Change in fair value of warrant liability
-
-
-1,885*
-
(loss)/gain on disposal of assets, net
-138
-
-
-
Gain on sale of assets
-
-
9*
-
Gain on lease termination
368
-
-
-
Other income/(loss), net
-1
15
-234*
45
Loss before tax
-
-
-179
-
Net loss
-1,326
-1,921
-179*
-1,532
Deemed dividend relating to warrant exchange
-
-
310*
-618
Net loss attributed to common shareholders
-1,326
-1,921
130
-2,150
Basic EPS
-0.21
-0.3
0.022
-0.4
Diluted EPS
-0.21
-0.3
0.022
-0.4
Basic Average Shares
6,406,191
6,406,191
5,899,573
5,435,829
Diluted Average Shares
6,406,191
6,406,191
5,899,573
5,435,829
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss attributed
to common...
-$1,326K
Net loss
-$1,326K
(74.72%↑ Y/Y)
Gain on lease
termination
$368K
Loss from operations
-$1,555K
(15.35%↑ Y/Y)
(loss)/gain on disposal of
assets, net
-$138K
(-225.45%↓ Y/Y)
Other income/(loss),
net
-$1K
(98.41%↑ Y/Y)
Total costs and
expenses
$1,555K
(-15.35%↓ Y/Y)
General and
administrative
$1,555K
(-15.35%↓ Y/Y)
Buy us a coffee
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)